History
  • No items yet
midpage
Calloway v. Caraco Pharmaceutical Laboratories, Ltd.
287 F.R.D. 402
E.D. Mich.
2012
Read the full case

Background

  • Calloway asserts Caraco violated WARN Act by failing to provide 60-day notice before layoffs tied to FDA shutdown orders.
  • Caraco admits mass layoffs occurred due to FDA directive but argues notice was given or not required for certain employees and evidence of waiver/release forms exists.
  • Two proposed subclasses: (A) those with 50+ layoffs where no 60-day notice and who did not sign certain arbitration/limitation forms or releases; (B) those with 50+ layoffs where prior authorization included arbitration but no six-month limitation and who did not sign a release.
  • Court considers Calloway’s motion for class certification, class counsel appointment, and approval of a proposed Notice of Class Action; Caraco does not oppose certification.
  • Court grants motion to certify class, appoints Kelman Loria, PLLC as class counsel, and approves the proposed Notice of Class Action.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether the WARN Act class can be certified under Rule 23 Calloway argues prerequisites 23(a) and 23(b)(3) are met. Caraco does not oppose certification and disputes no issue. Yes; the class is certifiable under 23(a) and 23(b)(3).
Whether numerosity is satisfied for the two subclasses Subclass sizes (~97 and ~72) are sufficient. No contrary argument presented. Numerosity satisfied; practical concerns met.
Whether commonality and typicality support certification Common question: whether FDA shutdown was reasonably foreseeable; typicality aligns with WARN claims. Individual facts (rates of pay, medical expenses, termination dates) do not defeat commonality. Commonality and typicality satisfied.
Whether the action is governed by Rule 23(b)(3) predominance and superiority Single course of conduct and class-wide issue predominate; class is superior due to limited damages and infeasibility of individual suits. Not disputed. Predominance and superiority satisfied; class certified.
Whether to appoint class counsel and approve class notice Kelman Loria, PLLC has conducted investigation and has relevant experience; notice language meets Rule 23(c)(2). No opposition to appointment or notice. Kelman Loria, PLLC appointed as class counsel; approved Notice of Class Action.

Key Cases Cited

  • Afro Am. Patrolmen’s League v. Duck, 503 F.2d 294 (6th Cir. 1974) (numerosity and commonality principles in class actions)
  • Beattie v. CenturyTel, Inc., 511 F.3d 554 (6th Cir. 2007) (framework for Rule 23(a) requirements and adequacy)
  • Gen. Tel. Co. of Sw. v. Falcon, 457 U.S. 147 (1982) (standard for typicality and adequacy in class actions)
  • In re Am. Med. Sys., Inc., 75 F.3d 1069 (6th Cir. 1996) (typicality and commonality in class certification)
  • Sprague v. Gen. Motors Corp., 133 F.3d 388 (6th Cir. 1998) (framework for common questions and class certification)
  • Senter v. Gen. Motors Corp., 532 F.2d 511 (6th Cir. 1976) (numerosity and class action prerequisites)
  • Wal-Mart Stores, Inc. v. Dukes, 131 S. Ct. 2541 (U.S. 2011) (importance of commonality and generalized proof)
  • Powers v. Hamilton Cnty. Pub. Defender Comm’n, 501 F.3d 592 (6th Cir. 2007) (predominance standard in 23(b)(3) actions)
  • Amchern Prods., Inc. v. Windsor, 521 U.S. 591 (1997) (class action framework and vindicating rights)
Read the full case

Case Details

Case Name: Calloway v. Caraco Pharmaceutical Laboratories, Ltd.
Court Name: District Court, E.D. Michigan
Date Published: Aug 17, 2012
Citation: 287 F.R.D. 402
Docket Number: No. 2:11-cv-15465
Court Abbreviation: E.D. Mich.